Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (241-250 of 350) with videos related to

Pageof 35
Sort By:
The Lancet. HIV|September 7, 2025
Epstein-Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trialJayne Ellis, Elisabetta Groppelli, Ronan Doyle, et al.
BMJ Open|June 16, 2023
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trialsHwanhee Hong, Anne Friedland, Mengyi Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum|June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis MeningitisEdwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Open Forum Infectious Diseases|December 31, 2015
Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal MeningitisMelissa A Rolfes, Joshua Rhein, Charlotte Schutz, et al.
Journal of Neurovirology|June 21, 2019
Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, UgandaLeah H Rubin, Deanna Saylor, Gertrude Nakigozi, et al.
Open Forum Infectious Diseases|August 11, 2018
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationJoshua Rhein, Kathy H Hullsiek, Emily E Evans, et al.
Plos Pathogens|March 13, 2015
Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infectionDarin L Wiesner, Charles A Specht, Chrono K Lee, et al.
AIDS (London, England)|April 23, 2025
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort studyJayne Ellis, Biyue Dai, Mable Kabahubya, et al.
Journal De Mycologie Medicale|July 10, 2021
Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan populationSarah Bridge, Kathy Huppler Hullsiek, Carol Nerima, et al.
Pageof 35

Showing results (241-250 of 350) with videos related to

Sort By:
Pageof 35
The Lancet. HIV|September 7, 2025
Epstein-Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trialJayne Ellis, Elisabetta Groppelli, Ronan Doyle, et al.
BMJ Open|June 16, 2023
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trialsHwanhee Hong, Anne Friedland, Mengyi Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
Microbiology Spectrum|June 21, 2022
Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis MeningitisEdwin Nuwagira, Kathy Huppler Hullsiek, Samuel Jjunju, et al.
Open Forum Infectious Diseases|December 31, 2015
Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal MeningitisMelissa A Rolfes, Joshua Rhein, Charlotte Schutz, et al.
Journal of Neurovirology|June 21, 2019
Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, UgandaLeah H Rubin, Deanna Saylor, Gertrude Nakigozi, et al.
Open Forum Infectious Diseases|August 11, 2018
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationJoshua Rhein, Kathy H Hullsiek, Emily E Evans, et al.
Plos Pathogens|March 13, 2015
Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infectionDarin L Wiesner, Charles A Specht, Chrono K Lee, et al.
AIDS (London, England)|April 23, 2025
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort studyJayne Ellis, Biyue Dai, Mable Kabahubya, et al.
Journal De Mycologie Medicale|July 10, 2021
Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan populationSarah Bridge, Kathy Huppler Hullsiek, Carol Nerima, et al.
Pageof 35